NIH-funded research R21 grant

Investigating how co-infection with two respiratory viruses affects their replication and spread

Official title: HMPV/RSV co-infection: effects on replication and viral spread

Funded at University of Kentucky · NIH-10906103 · Data updated 2026-11-12

This study is looking at how two viruses, RSV and HMPV, work together in the body and affect people, especially kids, older adults, and those with weakened immune systems, to help us understand how they make respiratory illnesses worse.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startAugust 11, 2023
Project endJuly 31, 2026
Funding year2024
Award (this year)$187,444
NIH project number5R21AI178798-02
Project IDNIH-10906103 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include pediatric, elderly, and immunocompromised patients who are experiencing respiratory infections.

Less likely to help

Patients with respiratory infections caused by other pathogens that do not involve RSV or HMPV may not benefit from this research.

What this research studies

This research focuses on the co-infection of respiratory syncytial virus (RSV) and human metapneumovirus (HMPV), which are known to cause severe respiratory illnesses, especially in vulnerable populations like children, the elderly, and immunocompromised individuals. The study aims to understand the molecular mechanisms behind how these two viruses interact within the body, particularly how they may compete for resources and influence each other's replication. By using advanced molecular techniques, the researchers will explore the formation of hybrid viral particles and the impact of co-infection on disease severity. This investigation could provide insights into the complexities of viral infections and their effects on patient health.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for patients suffering from severe respiratory infections caused by these viruses.

How similar studies have gone: While some studies have explored viral co-infections, this research aims to delve deeper into the specific interactions between RSV and HMPV, making it a novel investigation in this area.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Dutch, Rebecca E. — University of Kentucky
  • Study coordinator: Dutch, Rebecca E.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.